Quabodepistat is an investigational new drug of the antimycobacterial class that is being evaluated by Otsuka Pharmaceutical for the treatment of tuberculosis. It is a DprE1 enzyme inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.